Varian Medical Systems, Inc. (VAR)
|Net Income (ttm)||277.50M|
|Trading Day||March 5|
|Day's Range||175.40 - 175.99|
|52-Week Range||89.62 - 176.50|
CTSI Oncology Solutions, a Varian Company, to Provide Technology-Enabled Services for Radiation Oncology at CHRISTUS Health
PALO ALTO, Calif., Feb. 24, 2021 /PRNewswire/ -- CTSI Oncology Solutions, a Varian (NYSE: VAR) company that provides oncology services for healthcare providers worldwide, has entered into a lo...
EU antitrust regulators are set to grant conditional clearance to German health group Siemens Healthineers' $16.4-billion bid for U.S. peer Varian Medical Systems Inc, three people familiar wi...
First Eagle Investment (Trades, Portfolio) has revealed its portfolio for the fourth quarter of 2020. Major trades for the firm include reductions in Deere & Co. (NYSE:DE), Philip Morris Inter...
Varian Installs World's First ProBeam® 360° Proton Therapy System at Penn Medicine Lancaster General Health
PALO ALTO, Calif., Feb. 4, 2021 /PRNewswire/ -- Varian (NYSE: VAR) has started the installation of the cyclotron and gantry for its ProBeam® 360° single-room proton therapy system at Penn Medi...
Varian's (VAR) receipt of 13 Ethos orders in fiscal Q1 raises investors' optimism on the stock.
Varian Medical Systems, Inc. (VAR) delivered earnings and revenue surprises of 9.62% and -8.33%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead...
Varian's (VAR) fiscal first-quarter earnings are likely to reflect strength in Halcyon platform.
PALO ALTO, Calif., Jan. 19, 2021 /PRNewswire/ -- Varian (NYSE: VAR) has been recognized again as the leader in the annual IMV ServiceTrak™ Radiation Oncology Systems report, ranking first in a...
PALO ALTO, Calif., Jan. 8, 2021 /PRNewswire/ -- Varian (NYSE: VAR) today announced its first quarter fiscal year 2021 earnings release date. The Company will report results for the first quart...
Varian (VAR) will be coordinating with Yonsei Cancer Center on formulating AI solutions, which are proven to upgrade early detection of cancer.
Investor confidence is high on Varian Medical (VAR) stock, courtesy of solid prospects.
The third quarter was undeniably another bull run for stock markets with the major U.S. indexes reaching unprecedented highs. The S&P 500 surpassed 3,500 for the first time in history, the Nas...
Varian Medical Systems has key drivers in the growth engine that will continue to generate torque to the flywheel. The Siemens transaction highlights the company's standing as a leading author...
Varian and the Cincinnati Children's/UC Health Proton Therapy Center Announce Initial Patient Treated in the FAST-01 First Human Clinical Trial of FLASH Therapy for Cancer
PALO ALTO, Calif., and CINCINNATI, Ohio, Nov. 19, 2020 /PRNewswire/ -- Varian (NYSE: VAR) and the Cincinnati Children's/UC Health Proton Therapy Center today announce the start of the first cl...
Generation Investment Management, the firm founded by Al Gore (Trades, Portfolio) and David Blood, disclosed this week that its top five trades for the third quarter included a new position in...
In this article we present the list of Top 10 Stocks Billionaire George Soros Just Bought. Click to skip ahead and see the Top 5 Stocks Billionaire George Soros Just Bought .
Varian Medical Systems Invests in COTA, Inc. to Help Drive Faster, More Accurate Data-Driven Cancer Care
PALO ALTO, Calif., Nov. 10, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced a new $10M investment and collaboration agreement with COTA, Inc., a Boston-based curator of clinical data i...
Short interest on current S&P 500 Index (SPX) stocks is close to its lowest level in over a year.
Varian's (VAR) receipt of 10 Ethos orders in Q4 instills optimism
Varian's (VAR) solid Oncology platform is expected to have driven fiscal fourth-quarter performance.
PALO ALTO, Calif., Oct. 20, 2020 /PRNewswire/ -- Varian (NYSE: VAR) congratulates the United States Trade Representative and the Ministry of Development, Industry and Foreign Trade of Brazil o...
Varian Announces Presence at American Society for Radiation Oncology (ASTRO) Annual Meeting Highlighting Advancements in Intelligent Cancer Care™
PALO ALTO, Calif., Oct. 19, 2020 /PRNewswire/ -- Varian (NYSE: VAR), a leading provider of cancer care technologies and solutions, continues to reinforce its commitment to delivering Intellige...
PALO ALTO, Calif., Oct. 16, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced its fourth quarter of fiscal year 2020 earnings release date. The Company will report results for the fourth...
PALO ALTO, Calif., Oct. 15, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced that its stockholders have voted to approve the previously announced pending combination with Siemens Health...
The S&P 500 was up 8.5% in the third quarter, representing its best back-to-back quarter since 2009.
ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm
NEW YORK, Sept. 17, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating: Varian Medical Systems, Inc. (NYSE: VAR) concerning potential violations of the ...
Varian Expects to Benefit from the Extension of Medical Linear Accelerators Tariff Exclusion in China
PALO ALTO, Calif. and BEIJING, Sept.
PALO ALTO, Calif., Sept. 15, 2020 /PRNewswire/ -- Highlights: Integration of Dual Energy CT (DECT) images in the Eclipse planning process reduces range uncertainty and helps clinicians' spare ...
Varian's (VAR) Ethos therapy is being adopted in Germany, thus expanding the company's geographic footprint.
PALO ALTO, Calif., Sept. 14, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced the following leadership appointments, effective October 5, 2020: Chris Toth, Varian Oncology Systems Presi...
Varian's (VAR) Ethos Therapy used by Goshen Center for Cancer Care marks the expansion access to personalized cancer care.
Varian Announces Goshen Center for Cancer Care Treats First Patient with Ethos® Therapy, Expanding Access to Personalized Cancer Care
PALO ALTO, Calif., Sept. 10, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced the Goshen Center for Cancer Care in Goshen, Ind.
PALO ALTO, Calif. and DARMSTADT, Germany, Sept.
Varian (VAR) strengthens its partnership Proton Therapy Pte as it brings improved care to Singapore through Halcyon system.
Telix Pharmaceuticals Enters Strategic Collaboration with Varian Medical Systems for Advanced Prostate Imaging
MELBOURNE, Australia and PALO ALTO, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announced it has entered into a strategi...
Investor confidence is high in Varian Medical (VAR) stock at the moment.
Jobless claims were below one million for the first time since late March, and we have seen retail sales increase for July. It turns out, if you give the American people money to spend, they w...
VARIAN MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Varian Medical Systems, Inc. - VAR
NEW ORLEANS, Aug. 6, 2020 /PRNewswire/ -- Former Attorney General of Louisiana Charles C.
Varian's (VAR) Proton Solutions unit saw revenue growth in Q3.
Varian Medical Systems sees its Relative Strength Rating enter the elite 90-plus level. The post Stock Upgrades: Varian Medical Systems Shows Rising Relative Strength appeared first on Invest...
STOCKHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Varian Medical Systems, Inc. - VAR
NEW YORK, Aug. 4, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New...
NEW YORK, Aug. 3, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Varian Medical Systems, Inc.
A new force is emerging in cancer care.
VARIAN ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of VAR and Encourages Investors to Contact the Firm
NEW YORK--(BUSINESS WIRE)-- #Acquisition--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Vari...
Varian Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether The Sale Of Varian Medical Systems, Inc. Is Fair To Shareholders; Investors Are Encouraged To Contact The Firm
NEW YORK, Aug. 3, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Varian Medical Systems, Inc.
NEW YORK--(BUSINESS WIRE)--Rowley Law PLLC is investigating potential securities law violations by Varian Medical Systems, Inc. (NYSE: VAR) and its board of directors concerning the proposed a...
Siemens Healthineers plans a two-step capital increase to raise 7.5 billion euros ($8.80 billion) via share placements to help finance its acquisition of Varian Medical Systems , sources close...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Sale of Varian Medical Systems, Inc. to Siemens Healthineers AG
New York, New York--(Newsfile Corp. - August 3, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To view an enhanced version of this graphic, please visit:https://order...
Varian's (VAR) solid Oncology platform is expected to have driven fiscal third-quarter performance.
Siemens Healthineers to Buy Varian in $16.4 Billion Deal
Siemens Healthineers AG Chief Executive Officer Bernd Montag discusses the company's agreement to buy Varian Medical Systems for about $16.4 billion in cash in the biggest medical acquisition ...
Varian Medical Systems designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, artificial intelligence based adapti... [Read more...]
Medical Instruments & Supplies
|Stock Exchange |
|Ticker Symbol |
In 2020, VAR's revenue was $3.17 billion, a decrease of -1.76% compared to the previous year's $3.23 billion. Earnings were $269.20 million, a decrease of -7.78%.
According to 7 analysts, the average rating for VAR stock is "Hold." The 12-month stock price forecast is 177.75, which is an increase of 1.08% from the latest price.